Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:hasAssay |
gptkb:Homo_sapiens
functional binding |
| gptkbp:hasAssayTissue |
Cell
|
| gptkbp:hasBiologicalActivity |
Aurora kinase inhibitor
|
| gptkbp:hasInChIKey |
QJQYQJQJQJQJQJ-UHFFFAOYSA-N
|
| gptkbp:hasMolecularFormula |
C17H19N3O3
|
| gptkbp:hasSMILES |
COC1=CC=C(C=C1)NC(=O)C2=CN=C(C=C2N)[N+](=O)[O-]
|
| gptkbp:hasStandardType |
IC50
|
| gptkbp:hasStandardValue |
0.00013 μM (Aurora B)
0.00025 μM (Aurora C) |
| https://www.w3.org/2000/01/rdf-schema#label |
CHEMBL37539
|
| gptkbp:isApprovedDrug |
false
|
| gptkbp:isExperimentalDrug |
true
|
| gptkbp:IUPACName |
N-(4-methoxyphenyl)-6-(methylamino)-5-nitropyridine-3-carboxamide
|
| gptkbp:molecularWeight |
313.35
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL37539
21106313 25154816 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:synonym |
GSK1070916A
N-(4-methoxyphenyl)-6-(methylamino)-5-nitropyridine-3-carboxamide |
| gptkbp:target |
Aurora kinase B
Aurora kinase C |
| gptkbp:bfsParent |
gptkb:SR141716
|
| gptkbp:bfsLayer |
8
|